Pompano Beach, Fla., July 16, 2014 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc.(NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals, announced today that Mark Wolfson has joined its Board as an Independent Director and will serve on the Company's Audit Committee, and its Nominating and Corporate Governance Committee.
Mr. Wolfson is Managing Partner at Wolfson & Associates, a full service and licensed certified public accounting firm based in Coral Springs, Florida. Prior to founding the firm, Mr. Wolfson was First Vice President of Citizens Federal Bank, a $5 billion dollar financial institution. During his 8 years with the bank, he was involved with financial/SEC reporting, secondary marketing activities, REOs, and mergers and acquisitions. Mr. Wolfson continues to be involved with banking and as such, has served on the Board of Directors of Florida Bank as well as the Board of Directors of Mercantile Bank. Both banks were multi-billion dollar publicly traded financial institutions. He has served as a Senior Manager at Deloitte f/k/a Touche Ross & Co. for 9 years where he performed audits of both public and private entities in a variety of industries. Mr. Wolfson was also closely involved with initial and subsequent public offerings and performed numerous reviews of both public and private entities considered for acquisition and/or merger by his clients. Mr. Wolfson is a member of the American Institute of Certified Public Accountants, the Florida Institute of Certified Public Accountants, and the Association of Certified Fraud Examiners. He received his Bachelor of Science with honors from the University of Florida in 1976 and his Master of Business Administration from Tulane Graduate School of Business in 1978.
"DS Healthcare has a strong brand in the personal care products category with a solid track record of growth. I look forward to contributing to the Company's corporate governance as its business expands," Mr. Wolfson stated.
"Mark brings a tremendous amount of public company and SEC reporting and audit experience to our board. He also has relevant sector expertise in consumer healthcare and personal care products. This combined expertise makes him a valuable board member for DS Healthcare," stated DS Healthcare President and CEO Daniel Khesin.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Healthcare Group's flagship brand, visit www.dslaboratories.com
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
CONTACT: Laurel Moody Corporate Profile 1.646.810.0608
Source:DS Healthcare Group,Inc.